Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 221

1.

Genetic ancestry and population differences in levels of inflammatory cytokines in women: Role for evolutionary selection and environmental factors.

Yao S, Hong CC, Ruiz-Narváez EA, Evans SS, Zhu Q, Schaefer BA, Yan L, Coignet MV, Lunetta KL, Sucheston-Campbell LE, Lee K, Bandera EV, Troester MA, Rosenberg L, Palmer JR, Olshan AF, Ambrosone CB.

PLoS Genet. 2018 Jun 7;14(6):e1007368. doi: 10.1371/journal.pgen.1007368. eCollection 2018 Jun.

2.

A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women.

Bensen JT, Graff M, Young KL, Sethupathy P, Parker J, Pecot CV, Currin K, Haddad SA, Ruiz-Narváez EA, Haiman CA, Hong CC, Sucheston-Campbell LE, Zhu Q, Liu S, Yao S, Bandera EV, Rosenberg L, Lunetta KL, Ambrosone CB, Palmer JR, Troester MA, Olshan AF.

Breast Cancer Res. 2018 Jun 5;20(1):45. doi: 10.1186/s13058-018-0964-4.

3.

Consumption of Sugars, Sugary Foods, and Sugary Beverages in Relation to Cancer Risk: A Systematic Review of Longitudinal Studies.

Makarem N, Bandera EV, Nicholson JM, Parekh N.

Annu Rev Nutr. 2018 May 25. doi: 10.1146/annurev-nutr-082117-051805. [Epub ahead of print]

PMID:
29801420
4.

Associations of Whole and Refined Grain Intakes with Adiposity-Related Cancer Risk in the Framingham Offspring Cohort (1991-2013).

Makarem N, Bandera EV, Lin Y, McKeown NM, Hayes RB, Parekh N.

Nutr Cancer. 2018 May 21:1-11. doi: 10.1080/01635581.2018.1470647. [Epub ahead of print]

PMID:
29781707
5.

Anti-VEGF therapy - a role in obesity-related breast cancer.

Omene C, Bandera EV.

Nat Rev Endocrinol. 2018 Jun;14(6):329-330. doi: 10.1038/s41574-018-0021-5. No abstract available.

PMID:
29695750
6.

Circulating zearalenone and its metabolites differ in women due to body mass index and food intake.

Mauro T, Hao L, Pop LC, Buckley B, Schneider SH, Bandera EV, Shapses SA.

Food Chem Toxicol. 2018 Jun;116(Pt B):227-232. doi: 10.1016/j.fct.2018.04.027. Epub 2018 Apr 17.

PMID:
29678722
7.

Consumption of Sugars, Sugary Foods, and Sugary Beverages in Relation to Adiposity-Related Cancer Risk in the Framingham Offspring Cohort (1991-2013).

Makarem N, Bandera EV, Lin Y, Jacques PF, Hayes RB, Parekh N.

Cancer Prev Res (Phila). 2018 Jun;11(6):347-358. doi: 10.1158/1940-6207.CAPR-17-0218. Epub 2018 Apr 19.

PMID:
29674390
8.

Obesity, Body Composition, and Breast Cancer: An Evolving Science.

Bandera EV, John EM.

JAMA Oncol. 2018 Jun 1;4(6):804-805. doi: 10.1001/jamaoncol.2018.0125. No abstract available.

PMID:
29621383
9.

Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.

Peres LC, Risch H, Terry KL, M Webb P, Goodman MT, Wu AH, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Manichaikul A, Abbott SE, Camacho F, Jordan SJ, Nagle CM; Australian Ovarian Cancer Study Group, Anne Rossing M, Doherty JA, Modugno F, Moysich K, Ness R, Berchuck A, Cook L, Le N, Brooks-Wilson A, Sieh W, Whittemore A, McGuire V, Rothstein J, Anton-Culver H, Ziogas A, Pearce CL, Tseng C, Pike M, Schildkraut JM; African American Cancer Epidemiology Study and the Ovarian Cancer Association Consortium.

Int J Epidemiol. 2018 Mar 23. doi: 10.1093/ije/dyy054. [Epub ahead of print] No abstract available.

PMID:
29584862
10.

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.

Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W; Australian Ovarian Cancer Study Group, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, Doherty JA, Wicklund KG, Chang-Claude J, Jung AY, Moysich KB, Odunsi K, Goodman MT, Wilkens LR, Thompson PJ, Shvetsov YB, Dörk T, Park-Simon TW, Hillemanns P, Bogdanova N, Butzow R, Nevanlinna H, Pelttari LM, Leminen A, Modugno F, Ness RB, Edwards RP, Kelley JL, Heitz F, du Bois A, Harter P, Schwaab I, Karlan BY, Lester J, Orsulic S, Rimel BJ, Kjær SK, Høgdall E, Jensen A, Goode EL, Fridley BL, Cunningham JM, Winham SJ, Giles GG, Bruinsma F, Milne RL, Southey MC, Hildebrandt MAT, Wu X, Lu KH, Liang D, Levine DA, Bisogna M, Schildkraut JM, Berchuck A, Cramer DW, Terry KL, Bandera EV, Olson SH, Salvesen HB, Thomsen LCV, Kopperud RK, Bjorge L, Kiemeney LA, Massuger LFAG, Pejovic T, Bruegl A, Cook LS, Le ND, Swenerton KD, Brooks-Wilson A, Kelemen LE, Lubiński J, Huzarski T, Gronwald J, Menkiszak J, Wentzensen N, Brinton L, Yang H, Lissowska J, Høgdall CK, Lundvall L, Song H, Tyrer JP, Campbell I, Eccles D, Paul J, Glasspool R, Siddiqui N, Whittemore AS, Sieh W, McGuire V, Rothstein JH, Narod SA, Phelan C, Risch HA, McLaughlin JR, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pike MC, Tseng CC, Kupryjanczyk J, Dansonka-Mieszkowska A, Budzilowska A, Rzepecka IK, Webb PM; Ovarian Cancer Association Consortium.

Br J Cancer. 2018 Apr;118(8):1123-1129. doi: 10.1038/s41416-018-0011-3. Epub 2018 Mar 20.

PMID:
29555990
11.

Validity of self-reported weight, height, and body mass index among African American breast cancer survivors.

Qin B, Llanos AAM, Lin Y, Szamreta EA, Plascak JJ, Oh H, Pawlish K, Ambrosone CB, Demissie K, Hong CC, Bandera EV.

J Cancer Surviv. 2018 Mar 13. doi: 10.1007/s11764-018-0685-9. [Epub ahead of print]

PMID:
29536415
12.

Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES).

Mills AM, Peres LC, Meiss A, Ring KL, Modesitt SC, Abbott SE, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Wallace K, Schildkraut JM.

Int J Gynecol Pathol. 2018 Feb 26. doi: 10.1097/PGP.0000000000000494. [Epub ahead of print]

PMID:
29485423
13.

Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium.

Hong CC, Sucheston-Campbell LE, Liu S, Hu Q, Yao S, Lunetta KL, Haddad SA, Ruiz-Narváez EA, Bensen JT, Cheng TD, Bandera EV, Rosenberg LA, Haiman CA, Lee K, Evans SS, Abrams SI, Repasky EA, Olshan AF, Palmer JR, Ambrosone CB.

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):321-330. doi: 10.1158/1055-9965.EPI-17-0434. Epub 2018 Jan 16.

PMID:
29339359
14.

Dietary inflammatory index and ovarian cancer risk in a New Jersey case-control study.

Shivappa N, Hébert JR, Paddock LE, Rodriguez-Rodriguez L, Olson SH, Bandera EV.

Nutrition. 2018 Feb;46:78-82. doi: 10.1016/j.nut.2017.08.011. Epub 2017 Sep 23.

PMID:
29290361
15.

Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.

Peres LC, Risch H, Terry KL, Webb PM, Goodman MT, Wu AH, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Manichaikul A, Abbott SE, Camacho F, Jordan SJ, Nagle CM; Australian Ovarian Cancer Study Group, Rossing MA, Doherty JA, Modugno F, Moysich K, Ness R, Berchuck A, Cook L, Le N, Brooks-Wilson A, Sieh W, Whittemore A, McGuire V, Rothstein J, Anton-Culver H, Ziogas A, Pearce CL, Tseng C, Pike M, Schildkraut JM; African American Cancer Epidemiology Study and the Ovarian Cancer Association Consortium.

Int J Epidemiol. 2018 Apr 1;47(2):460-472. doi: 10.1093/ije/dyx252.

PMID:
29211900
16.

Recreational physical activity and survival in African-American women with ovarian cancer.

Abbott SE, Camacho F, Peres LC, Alberg AJ, Bandera EV, Bondy M, Cote ML, Funkhouser E, Moorman PG, Peters ES, Qin B, Schwartz AG, Barnholtz-Sloan J, Terry P, Schildkraut JM.

Cancer Causes Control. 2018 Jan;29(1):77-86. doi: 10.1007/s10552-017-0986-8. Epub 2017 Nov 29.

PMID:
29188593
17.

Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium.

Harris HR, Babic A, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjær SK, Høgdall E, Jensen A, Schildkraut JM, Berchuck A, Cramer DW, Bandera EV, Wentzensen N, Kotsopoulos J, Narod SA, Phelan CM, McLaughlin JR, Anton-Culver H, Ziogas A, Pearce CL, Wu AH, Terry KL; Ovarian Cancer Association Consortium; Australian Ovarian Cancer Study Group.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):174-182. doi: 10.1158/1055-9965.EPI-17-0655. Epub 2017 Nov 15.

PMID:
29141849
18.

Genetic variations, reproductive aging, and breast cancer risk in African American and European American women: The Women's Circle of Health Study.

Coignet MV, Zirpoli GR, Roberts MR, Khoury T, Bandera EV, Zhu Q, Yao S.

PLoS One. 2017 Oct 26;12(10):e0187205. doi: 10.1371/journal.pone.0187205. eCollection 2017.

19.

Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER Consortium.

Chollet-Hinton L, Olshan AF, Nichols HB, Anders CK, Lund JL, Allott EH, Bethea TN, Hong CC, Cohen SM, Khoury T, Zirpoli GR, Borges VF, Rosenberg LA, Bandera EV, Ambrosone CB, Palmer JR, Troester MA.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1722-1729. doi: 10.1158/1055-9965.EPI-17-0450. Epub 2017 Sep 13.

PMID:
28903991
20.

Tubal ligation and ovarian cancer risk in African American women.

McNamara C, Abbott SE, Bandera EV, Qin B, Peres LC, Camacho F, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Schildkraut JM, Terry P.

Cancer Causes Control. 2017 Oct;28(10):1033-1041. doi: 10.1007/s10552-017-0943-6. Epub 2017 Sep 4.

PMID:
28871344

Supplemental Content

Loading ...
Support Center